There are more than 500 biopharmaceuticals on the market, including more than 200 therapeutic proteins, making biologics the fastest growing sector in the biopharmaceutical market. These products include more than 40 monoclonal antibodies, for indications ranging from treatment or mitigation of various types of cancer to rheumatoid arthritis.
The clinical application of these therapeutic peptides and proteins is limited by several problems, such as lack of physical and chemical stability or the lack of desirable attributes for adequate absorption or distribution. Thus, as these therapeutic peptides and proteins are made available, it will be essential to formulate these drugs into safe, stable, and efficacious delivery systems. The pharmaceutical scientist involved in this effort needs to call upon the knowledge of several disciplines, such as pharmaceutics, medicinal chemistry, biochemistry, microbiology, and chemical engineering and needs to keep abreast with the latest research in the published literature.
Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition
provides a comprehensive overview of the field for scientists in industry and academia and for students, while also providing practical information on the challenges facing the formulation and delivery aspects of these unique macromolecules. In particular, the book:
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Ajay K. Banga is a professor and chair of the Department of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, Mercer University, Atlanta, Georgia. He obtained a PhD in pharmaceutics from Rutgers University, New Jersey. Dr. Banga is currently a major advisor to eight PhD students. He currently serves on the editorial board of eight journals and has also served as the Editor-in-Chief for one drug delivery journal. He has served on over 30 thesis/dissertation advisory committees and as a referee for more than 28 journals. Dr. Banga is a fellow of the American Association of Pharmaceutical Scientists. He has written more than 220 publications and scientific abstracts.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 23523621
Quantité disponible : 10 disponible(s)
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 23523621
Quantité disponible : 10 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. pp. 476. N° de réf. du vendeur 95277374
Quantité disponible : 3 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 23523621-n
Quantité disponible : 10 disponible(s)
Vendeur : Books Puddle, Woodside, NY, Etats-Unis
Etat : New. pp. 476 3rd Edition. N° de réf. du vendeur 2698201313
Quantité disponible : 3 disponible(s)
Vendeur : moluna, Greven, Allemagne
Etat : New. Ajay K. Banga is a professor and chair of the Department of Pharmaceutical Sciences at the College of Pharmacy and Health Sciences, Mercer University, Atlanta, Georgia. He obtained a PhD in pharmaceutics from Rutgers University, New Jersey. Dr. Banga is . N° de réf. du vendeur 36911561
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 23523621-n
Quantité disponible : 10 disponible(s)
Vendeur : Biblios, Frankfurt am main, HESSE, Allemagne
Etat : New. pp. 476. N° de réf. du vendeur 1898201323
Quantité disponible : 3 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Neuware - There are more than 500 biopharmaceuticals on the market, including more than 200 therapeutic proteins, making biologics the fastest growing sector in the biopharmaceutical market. These products include more than 40 monoclonal antibodies, for indications ranging from treatment or mitigation of various types of cancer to rheumatoid arthritis. The clinical application of these therapeutic peptides and proteins is limited by several problems, such as lack of physical and chemical stability or the lack of desirable attributes for adequate absorption or distribution. Thus, as these therapeutic peptides and proteins are made available, it will be essential to formulate these drugs into safe, stable, and efficacious delivery systems. The pharmaceutical scientist involved in this effort needs to call upon the knowledge of several disciplines, such as pharmaceutics, medicinal chemistry, biochemistry, microbiology, and chemical engineering and needs to keep abreast with the latest research in the published literature.Therapeutic Peptides and Proteins: Formulation, Processing, and Delivery Systems, Third Edition provides a comprehensive overview of the field for scientists in industry and academia and for students, while also providing practical information on the challenges facing the formulation and delivery aspects of these unique macromolecules. In particular, the book: - Explains how recombinant DNA techniques now allow us to produce therapeutic proteins in a commercially viable form - Discusses the physical and chemical pathways of peptide and protein degradation - Includes a detailed discussion of protein formulation and lyophilization - Overviews the pharmacokinetic aspects of therapeutic peptides and proteins and discusses controlled delivery systems for parenteral administration, including microsphere formulations - Discusses research progress on oral, transdermal, mucosal, and topical delivery systems discusses transdermal and topical delivery. N° de réf. du vendeur 9781466566064
Quantité disponible : 2 disponible(s)
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Hardcover. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA829146656606X6
Quantité disponible : 1 disponible(s)